{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:00:26Z","timestamp":1773280826567,"version":"3.50.1"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T00:00:00Z","timestamp":1427932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0122048","type":"journal-article","created":{"date-parts":[[2015,4,3]],"date-time":"2015-04-03T11:51:44Z","timestamp":1428061904000},"page":"e0122048","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":63,"title":["Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis"],"prefix":"10.1371","volume":"10","author":[{"given":"Shahin","family":"Aeinehband","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rickard P. F.","family":"Lindblom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiez","family":"Al Nimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swetha","family":"Vijayaraghavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Sandholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Khademi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina Nilsson","family":"Ekdahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taher","family":"Darreh-Shori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Piehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,4,2]]},"reference":[{"issue":"9648","key":"ref1","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"A Compston","year":"2008","journal-title":"Lancet"},{"issue":"Pt 3","key":"ref2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/brain\/awl007","article-title":"Natural history of multiple sclerosis: a unifying concept","volume":"129","author":"C Confavreux","year":"2006","journal-title":"Brain"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/1352458510364992","article-title":"Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis","volume":"16","author":"EC Tallantyre","year":"2010","journal-title":"Mult Scler"},{"issue":"Pt 7","key":"ref4","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/awq076","article-title":"Evidence for a two-stage disability progression in multiple sclerosis","volume":"133","author":"E Leray","year":"2010","journal-title":"Brain"},{"issue":"Suppl 1","key":"ref5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00415-008-1002-8","article-title":"A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis","volume":"255","author":"HL Weiner","year":"2008","journal-title":"J Neurol"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"e19138","DOI":"10.1371\/journal.pone.0019138","article-title":"The expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosis","volume":"6","author":"E Iacobaeus","year":"2011","journal-title":"PloS one"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"B Serafini","year":"2004","journal-title":"Brain Pathol"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2249.2008.03830.x","article-title":"Complement in multiple sclerosis: its role in disease and potential as a biomarker","volume":"155","author":"G Ingram","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"C Lucchinetti","year":"2000","journal-title":"Annals of neurology"},{"issue":"Pt 6","key":"ref10","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/brain\/awq085","article-title":"Complement regulator factor H as a serum biomarker of multiple sclerosis disease state","volume":"133","author":"G Ingram","year":"2010","journal-title":"Brain"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Ingram G, Hakobyan S, Hirst C, Harris C, Loveless S, Mitchell J, et al. Systemic complement profiling in multiple sclerosis as a biomarker of disease state. Mult Scler. 2012. Epub 2012\/02\/23. <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1177\/1352458512438238\" xlink:type=\"simple\">10.1177\/1352458512438238<\/ext-link><\/comment> <object-id pub-id-type=\"pmid\">22354735<\/object-id>.","DOI":"10.1177\/1352458512438238"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/jcb.23204","article-title":"Complement Regulator Factor H in Multiple Sclerosis","volume":"112","author":"G Ingram","year":"2011","journal-title":"J Cell Biochem"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1177\/1352458511399614","article-title":"Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry","volume":"17","author":"CE Teunissen","year":"2011","journal-title":"Mult Scler"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/jcb.23113","article-title":"Differential expression of complement proteins in cerebrospinal fluid from active multiple sclerosis patients","volume":"112","author":"Y Li","year":"2011","journal-title":"J Cell Biochem"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1177\/1352458511399614","article-title":"Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry","volume":"17","author":"CE Teunissen","year":"2011","journal-title":"Mult Scler"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/pmic.200700446","article-title":"Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry","volume":"8","author":"MP Stoop","year":"2008","journal-title":"Proteomics"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ajpath.2011.01.006","article-title":"Complement 3 and factor h in human cerebrospinal fluid in Parkinson&apos;s disease, Alzheimer&apos;s disease, and multiple-system atrophy","volume":"178","author":"Y Wang","year":"2011","journal-title":"The American journal of pathology"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.nbd.2006.05.016","article-title":"Genetically determined susceptibility to neurodegeneration is associated with expression of inflammatory genes","volume":"24","author":"M Swanberg","year":"2006","journal-title":"Neurobiol Dis"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.4049\/jimmunol.1301233","article-title":"Unbiased expression mapping identifies a link between the complement and cholinergic systems in the rat central nervous system","volume":"192","author":"RP Lindblom","year":"2014","journal-title":"Journal of immunology"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/hmg\/6.11.1933","article-title":"Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer&apos;s disease","volume":"6","author":"DJ Lehmann","year":"1997","journal-title":"Hum Mol Genet"},{"key":"ref21","unstructured":"Darreh-Shori T, Vijayaraghavan S, Aeinehband S, Piehl F, Lindblom RP, Nilsson B, et al. Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer&apos;s disease. Neurobiol Aging. 2013. Epub 2013\/06\/14. doi: S0197-4580(13)00195-4 [pii] <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1016\/j.neurobiolaging.2013.04.027\" xlink:type=\"simple\">10.1016\/j.neurobiolaging.2013.04.027<\/ext-link><\/comment> <object-id pub-id-type=\"pmid\">23759148<\/object-id>."},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/jnnp.50.5.538","article-title":"Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems","volume":"50","author":"M Ruberg","year":"1987","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1\u20133","key":"ref23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cbi.2010.01.037","article-title":"Butyrylcholinesterase activity in multiple sclerosis neuropathology","volume":"187","author":"S Darvesh","year":"2010","journal-title":"Chem Biol Interact"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00401-011-0849-4","article-title":"Cholinergic imbalance in the multiple sclerosis hippocampus","volume":"122","author":"EJ Kooi","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10072-012-1265-9","article-title":"Biological markers in cerebrospinal fluid for axonal impairment in multiple sclerosis: acetylcholinesterase activity cannot be considered a useful biomarker","volume":"34","author":"T Antonelli","year":"2013","journal-title":"Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"WI McDonald","year":"2001","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"ref27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jneuroim.2006.10.022","article-title":"Complement activation in Lyme neuroborreliosis\u2014increased levels of C1q and C3a in cerebrospinal fluid indicate complement activation in the CNS","volume":"183","author":"AJ Henningsson","year":"2007","journal-title":"J Neuroimmunol"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.nbd.2006.07.013","article-title":"Differential CSF butyrylcholinesterase levels in Alzheimer&apos;s disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism","volume":"24","author":"T Darreh-Shori","year":"2006","journal-title":"Neurobiology of disease"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neurobiolaging.2006.09.020","article-title":"Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine","volume":"29","author":"T Darreh-Shori","year":"2008","journal-title":"Neurobiol Aging"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ng.2770","article-title":"Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis","volume":"45","author":"AH Beecham","year":"2013","journal-title":"Nature genetics"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1474-4422(04)00964-0","article-title":"Biological markers in CSF and blood for axonal degeneration in multiple sclerosis","volume":"4","author":"CE Teunissen","year":"2005","journal-title":"Lancet Neurol"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ana.22247","article-title":"Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab","volume":"69","author":"M Gunnarsson","year":"2011","journal-title":"Annals of neurology"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Kuhle J, Plattner K, Bestwick JP, Lindberg RL, Ramagopalan SV, Norgren N, et al. A comparative study of CSF neurofilament light and heavy chain protein in MS. Mult Scler. 2013. Epub 2013\/03\/27. doi: 1352458513482374 [pii] <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1177\/1352458513482374\" xlink:type=\"simple\">10.1177\/1352458513482374<\/ext-link><\/comment> <object-id pub-id-type=\"pmid\">23529999<\/object-id>.","DOI":"10.1177\/1352458513482374"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.neurobiolaging.2013.04.027","article-title":"Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer&apos;s disease","volume":"34","author":"T Darreh-Shori","year":"2013","journal-title":"Neurobiology of aging"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrn1035","article-title":"Neurobiology of butyrylcholinesterase","volume":"4","author":"S Darvesh","year":"2003","journal-title":"Nature reviews Neuroscience"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ana.22247","article-title":"Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab","volume":"69","author":"M Gunnarsson","year":"2011","journal-title":"Ann Neurol"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"e63172","DOI":"10.1371\/journal.pone.0063172","article-title":"Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers","volume":"8","author":"M Khademi","year":"2013","journal-title":"PLoS One"},{"issue":"Pt 5","key":"ref38","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains","volume":"132","author":"JM Frischer","year":"2009","journal-title":"Brain"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"H Lassmann","year":"2012","journal-title":"Nature reviews Neurology"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Axelsson M, Malmestrom C, Gunnarsson M, Zetterberg H, Sundstrom P, Lycke J, et al. Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis. Mult Scler. 2013. Epub 2013\/05\/25. doi: 1352458513490544 [pii] <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1177\/1352458513490544\" xlink:type=\"simple\">10.1177\/1352458513490544<\/ext-link><\/comment> <object-id pub-id-type=\"pmid\">23702432<\/object-id>.","DOI":"10.1177\/1352458513490544"},{"issue":"Suppl 1","key":"ref41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00415-008-1002-8","article-title":"A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis","volume":"255","author":"HL Weiner","year":"2008","journal-title":"Journal of neurology"},{"issue":"10","key":"ref42","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"PF Zipfel","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1073\/pnas.1111924109","article-title":"C3-dependent mechanism of microglial priming relevant to multiple sclerosis","volume":"109","author":"V Ramaglia","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"49","key":"ref44","doi-asserted-by":"crossref","first-page":"20960","DOI":"10.1073\/pnas.0911405106","article-title":"Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice","volume":"106","author":"IM Chiu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","article-title":"Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer&apos;s disease","volume":"183","author":"MI Fonseca","year":"2009","journal-title":"J Immunol"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.it.2008.11.003","article-title":"Complement activation and inhibition: a delicate balance","volume":"30","author":"AP Sjoberg","year":"2009","journal-title":"Trends in immunology"},{"issue":"9","key":"ref47","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"D Ricklin","year":"2010","journal-title":"Nat Immunol"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/ahg.12000","article-title":"Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk Loci","volume":"77","author":"P Holton","year":"2013","journal-title":"Ann Hum Genet"},{"issue":"6052","key":"ref49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1209985","article-title":"Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit","volume":"334","author":"M Rosas-Ballina","year":"2011","journal-title":"Science"},{"issue":"5","key":"ref50","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.neuropharm.2005.10.013","article-title":"Anti-inflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitors","volume":"50","author":"E Nizri","year":"2006","journal-title":"Neuropharmacology"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-2094-2-4","article-title":"Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures","volume":"2","author":"R De Simone","year":"2005","journal-title":"J Neuroinflammation"},{"issue":"9716","key":"ref52","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(09)61158-2","article-title":"Systemic infection and delirium: when cytokines and acetylcholine collide","volume":"375","author":"WA van Gool","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.4049\/jimmunol.182.3.1730","article-title":"Nicotinic attenuation of central nervous system inflammation and autoimmunity","volume":"182","author":"FD Shi","year":"2009","journal-title":"J Immunol"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Parada E, Egea J, Buendia I, Negredo P, Cunha AC, Cardoso S, et al. The Microglial alpha7-Acetylcholine Nicotinic Receptor Is a Key Element in Promoting Neuroprotection by Inducing Heme Oxygenase-1 via Nuclear Factor Erythroid-2-Related Factor 2. Antioxid Redox Signal. 2013. Epub 2013\/01\/15. <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1089\/ars.2012.4671\" xlink:type=\"simple\">10.1089\/ars.2012.4671<\/ext-link><\/comment> <object-id pub-id-type=\"pmid\">23311871<\/object-id>.","DOI":"10.1089\/ars.2012.4671"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Sifringer M, Bendix I, von Haefen C, Endesfelder S, Kalb A, Buhrer C, et al. Oxygen Toxicity Is Reduced by Acetylcholinesterase Inhibition in the Developing Rat Brain. Dev Neurosci. 2013. Epub 2013\/03\/01. doi: 000346723 [pii] <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1159\/000346723\" xlink:type=\"simple\">10.1159\/000346723<\/ext-link><\/comment> <object-id pub-id-type=\"pmid\">23445753<\/object-id>.","DOI":"10.1159\/000346723"},{"issue":"3","key":"ref56","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/STROKEAHA.111.639989","article-title":"alpha7 nicotinic acetylcholine receptor agonism confers neuroprotection through GSK-3beta inhibition in a mouse model of intracerebral hemorrhage","volume":"43","author":"PR Krafft","year":"2012","journal-title":"Stroke"},{"issue":"3","key":"ref57","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1023\/A:1010947205224","article-title":"Butyrylcholinesterase-Mediated enhancement of the enzymatic activity of trypsin","volume":"21","author":"S Darvesh","year":"2001","journal-title":"Cellular and molecular neurobiology"},{"issue":"3","key":"ref58","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/(SICI)1096-9861(19980413)393:3<374::AID-CNE8>3.0.CO;2-Z","article-title":"Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation","volume":"393","author":"S Darvesh","year":"1998","journal-title":"The Journal of comparative neurology"},{"issue":"9","key":"ref59","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/jcmm.12343","article-title":"Fibrillar beta-amyloid 1\u201342 alters cytokine secretion, cholinergic signalling and neuronal differentiation","volume":"18","author":"L Malmsten","year":"2014","journal-title":"Journal of cellular and molecular medicine"},{"issue":"6","key":"ref60","doi-asserted-by":"crossref","first-page":"e65936","DOI":"10.1371\/journal.pone.0065936","article-title":"Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway","volume":"8","author":"S Vijayaraghavan","year":"2013","journal-title":"PloS one"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Malmsten L, Vijayaraghavan S, Hovatta O, Marutle A, Darreh-Shori T. Fibrillar beta-amyloid 1\u201342 alters cytokine secretion, cholinergic signalling and neuronal differentiation. J Cell Mol Med 2014 Aug 11 doi: 101111\/jcmm12343. 2014. Epub 2014\/08\/12. <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1111\/jcmm.12343\" xlink:type=\"simple\">10.1111\/jcmm.12343<\/ext-link><\/comment> <object-id pub-id-type=\"pmid\">25109373<\/object-id>.","DOI":"10.1111\/jcmm.12343"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0122048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T17:54:41Z","timestamp":1566496481000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0122048"}},"subtitle":[],"editor":[{"given":"Israel","family":"Silman","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,2]]},"references-count":61,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0122048","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,2]]}}}